title: Induction of epitope-specific neutralizing antibodies against West Nile virus.
abstract: Previous studies have established that an epitope on the lateral ridge of domain III (DIII-lr) of West Nile virus (WNV) envelope (E) protein is recognized by strongly neutralizing type-specific antibodies. In contrast, an epitope against the fusion loop in domain II (DII-fl) is recognized by flavivirus cross-reactive antibodies with less neutralizing potential. Using gain- and loss-of-function E proteins and wild-type and variant WNV reporter virus particles, we evaluated the expression pattern and activity of antibodies against the DIII-lr and DII-fl epitopes in mouse and human serum after WNV infection. In mice, immunoglobulin M (IgM) antibodies to the DIII-lr epitope were detected at low levels at day 6 after infection. However, compared to IgG responses against other epitopes in DI and DII, which were readily detected at day 8, the development of IgG against DIII-lr epitope was delayed and did not appear consistently until day 15. This late time point is notable since almost all death after WNV infection in mice occurs by day 12. Nonetheless, at later time points, DIII-lr antibodies accumulated and comprised a significant fraction of the DIII-specific IgG response. In sera from infected humans, DIII-lr antibodies were detected at low levels and did not correlate with clinical outcome. In contrast, antibodies to the DII-fl were detected in all human serum samples and encompassed a significant percentage of the anti-E protein response. Our experiments suggest that the highly neutralizing DIII-lr IgG antibodies have little significant role in primary infection and that the antibody response of humans may be skewed toward the induction of cross-reactive, less-neutralizing antibodies.
authors: Departments of Medicine, Molecular Microbiology, and Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
authors: Theodore
authors: T
authors: Oliphant
authors: Grant E
authors: GE
authors: Nybakken
authors: S Kyle
authors: SK
authors: Austin
authors: Qing
authors: Q
authors: Xu
authors: Jonathan
authors: J
authors: Bramson
authors: Mark
authors: M
authors: Loeb
authors: Mark
authors: M
authors: Throsby
authors: Daved H
authors: DH
authors: Fremont
authors: Theodore C
authors: TC
authors: Pierson
authors: Michael S
authors: MS
authors: Diamond
mesh_terms: D000818:Animals; D000906:Antibodies / Q000737:chemistry*; D003001:Cloning, Molecular; D017931:DNA Primers / Q000737:chemistry; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000737:chemistry*; D006801:Humans; D007074:Immunoglobulin G / Q000737:chemistry; D007075:Immunoglobulin M / Q000737:chemistry; D051379:Mice; D008810:Mice, Inbred C57BL; D017510:Protein Folding; D020349:Surface Plasmon Resonance; D053060:West Nile Virus Vaccines / Q000737:chemistry; D014902:West Nile virus / Q000737:chemistry / Q000276:immunology*
chemical_list: D000906:Antibodies; D017931:DNA Primers; D000939:Epitopes; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D053060:West Nile Virus Vaccines
references: Science. 2003 Oct 10;302(5643):248
references: 14551429
references: Virology. 2006 Nov 10;355(1):44-51
references: 16904151
references: J Virol. 2003 Dec;77(24):13323-34
references: 14645588
references: J Exp Med. 2003 Dec 15;198(12):1853-62
references: 14662909
references: Dev Biol (Basel). 2003;114:221-7
references: 14677692
references: Nature. 2004 Jan 22;427(6972):313-9
references: 14737159
references: EMBO J. 2004 Feb 25;23(4):728-38
references: 14963486
references: Science. 1999 Dec 10;286(5447):2156-9
references: 10591647
references: Science. 1999 Dec 17;286(5448):2333-7
references: 10600742
references: J Exp Med. 2000 Jul 17;192(2):271-80
references: 10899913
references: J Virol. 2001 Apr;75(8):4002-7
references: 11264392
references: J Virol. 2001 May;75(9):4268-75
references: 11287576
references: Nat Immunol. 2001 May;2(5):410-4
references: 11323694
references: N Engl J Med. 2001 Jun 14;344(24):1807-14
references: 11407341
references: Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7449-54
references: 11404475
references: J Virol. 2001 Aug;75(16):7769-73
references: 11462053
references: J Immunol. 2001 Nov 1;167(9):5273-7
references: 11673542
references: Cell. 2002 Mar 8;108(5):717-25
references: 11893341
references: Nucleic Acids Res. 2002 May 15;30(10):e43
references: 12000848
references: J Virol. 2002 Dec;76(24):13097-100
references: 12438639
references: J Virol. 2003 Feb;77(4):2578-86
references: 12551996
references: J Virol. 2006 Dec;80(23):11467-74
references: 16987985
references: J Virol. 2006 Dec;80(24):12149-59
references: 17035317
references: Vaccine. 2007 Jan 5;25(3):414-23
references: 16996661
references: J Immunol. 2007 Feb 1;178(3):1692-701
references: 17237419
references: J Immunol. 2007 Mar 1;178(5):2699-705
references: 17312111
references: Virology. 2007 Mar 15;359(2):336-48
references: 17055550
references: Cell Host Microbe. 2007 Apr 19;1(2):135-45
references: 18005691
references: Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91
references: 12759475
references: J Infect Dis. 2003 Jul 1;188(1):5-12
references: 12825165
references: Virology. 2003 Sep 15;314(1):190-5
references: 14517072
references: Structure. 2004 Sep;12(9):1607-18
references: 15341726
references: Am J Trop Med Hyg. 1987 Mar;36(2):427-34
references: 3826503
references: Nature. 1991 Dec 5;354(6352):389-92
references: 1956400
references: Cell. 1991 Dec 20;67(6):1121-9
references: 1760840
references: Virology. 1994 Jun;201(2):285-93
references: 7514319
references: J Med Virol. 1997 Jul;52(3):309-15
references: 9210041
references: J Gen Virol. 1998 Oct;79 ( Pt 10):2375-80
references: 9780042
references: J Virol. 1999 Jan;73(1):783-6
references: 9847388
references: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2250-5
references: 10051627
references: J Virol. 2004 Dec;78(23):12919-28
references: 15542644
references: J Virol. 2004 Dec;78(24):13975-86
references: 15564505
references: Nat Med. 2004 Dec;10(12):1366-73
references: 15558055
references: J Gen Virol. 2005 Feb;86(Pt 2):405-12
references: 15659760
references: Virology. 2005 May 25;336(1):70-82
references: 15866072
references: Nat Med. 2005 May;11(5):522-30
references: 15852016
references: Vaccine. 2005 Jun 10;23(30):3915-24
references: 15917113
references: J Virol. 2005 Jun;79(12):7466-77
references: 15919902
references: J Virol. 2005 Jul;79(13):8339-47
references: 15956579
references: Nature. 2005 Sep 29;437(7059):764-9
references: 16193056
references: J Virol. 2005 Dec;79(23):14606-13
references: 16282460
references: Virology. 2006 Mar 1;346(1):53-65
references: 16325883
references: J Gene Med. 2006 Mar;8(3):265-74
references: 16308885
references: Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6694-9
references: 16617103
references: J Exp Med. 2006 May 15;203(5):1371-81
references: 16651386
references: J Virol. 2006 Jul;80(14):6982-92
references: 16809304
references: Virology. 2006 Aug 1;351(2):432-43
references: 16712897
references: Virology. 2006 Sep 15;353(1):35-40
references: 16806383
references: J Virol. 2006 Oct;80(19):9557-68
references: 16973559
references: J Infect Dis. 2006 Nov 1;194(9):1300-8
references: 17041857
references: J Virol. 2003 Dec;77(24):12941-9
references: 14645550